Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
40.2M
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
8.78M
-
Shares change
-
-420K
-
Total reported value, excl. options
-
$212M
-
Value change
-
-$5.8M
-
Number of buys
-
26
-
Number of sells
-
-14
-
Price
-
$24.21
Significant Holders of Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) as of Q4 2020
52 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2020.
Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) has 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.78M shares
of 40.2M outstanding shares and own 21.81% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (2.56M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (783K shares), Ikarian Capital, LLC (650K shares), Rock Springs Capital Management LP (643K shares), PERCEPTIVE ADVISORS LLC (609K shares), ORBIMED ADVISORS LLC (450K shares), PRICE T ROWE ASSOCIATES INC /MD/ (434K shares), Artisan Partners Limited Partnership (377K shares), FRANKLIN RESOURCES INC (350K shares), and Cormorant Asset Management, LP (350K shares).
This table shows the top 49 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.